is farxiga a glp 1 www.economist.com/content-assets/images/20241026_F Are GLP-1s Safe? Everything You

The hypothalamus, particularly the arcuate nucleus, contains GLP-1 receptors that modulate hunger and satiety signals

Were not interested in building more products

PMID 19410575

Seek immediate medical attention if you experience: Severe dizziness accompanied by chest pain, shortness of breath, or palpitations Dizziness with loss of consciousness or near-fainting episodes Dizziness associated with severe headache, visual changes, or neurological symptoms such as weakness, numbness, or difficulty speaking Signs of severe dehydration, including decreased urination, extreme thirst, confusion, or rapid heartbeat Symptoms suggestive of hypoglycemia that do not resolve with carbohydrate intake Severe abdominal pain with or without vomiting (possible pancreatitis) Signs of allergic reaction such as rash, itching, swelling of face/throat, or difficulty breathing Prolonged vomiting or diarrhea lasting more than 24 hours (risk of dehydration and kidney injury) Contact your healthcare provider within 24-48 hours if: Dizziness persists for more than a few days despite hydration and positional precautions You experience frequent episodes of lightheadedness that interfere with daily activities Dizziness worsens after a dose increase You have documented orthostatic hypotension (significant blood pressure drop upon standing) Dizziness is accompanied by persistent nausea, vomiting, or diarrhea Your healthcare provider may recommend laboratory testing to evaluate electrolytes, kidney function, and glucose levels

CONCLUSIONS GLP-1-RAs may provide clinical benefits for patients with IIH, improving outcomes and reducing the need for invasive interventions